Skip to content

Immunological Mechanisms and Risk Prediction Model of Urinary Tract Infection in Children With Vesicoureteral Reflux: A Study Integrating Single-Cell Transcriptomics and Multi-factor Clinical Data

Immunological Mechanisms and Risk Prediction Model of Urinary Tract Infection in Children With Vesicoureteral Reflux: A Study Integrating Single-Cell Transcriptomics and Multi-factor Clinical Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114382
Enrollment
Unknown
Registered
2025-12-11
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infection

Interventions

Recurrent UTI Group :None
Non-recurrent UTI Group :None

Sponsors

Hebei Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Children aged 0–18 years; 2.Diagnosed with vesicoureteral reflux (VUR) confirmed by imaging studies; 3.Diagnostic criteria for UTI: at least one of the following conditions must be met: (1) Typical clinical symptoms + laboratory support Clinical symptoms (at least one): fever (>=38°C), frequent urination, urgency, dysuria, lower abdominal pain, or flank pain; Laboratory support (at least one): positive urine leukocytes (urinalysis WBC >=10/µL or microscopy >=5/HPF), hematuria, or positive urine culture (>=10^5 CFU/mL of a single pathogen). (2) Special presentations in neonates and infants Abnormal body temperature (high fever or unstable temperature), feeding difficulties, vomiting, poor appetite, irritability, or lethargy, accompanied by a positive urine culture; 4.Informed consent obtained from the legal guardian, voluntary participation, and ability to complete follow-up and related examinations.

Exclusion criteria

Exclusion criteria: 1.Presence of other severe urinary tract structural abnormalities or congenital malformations (e.g., bladder exstrophy, hypospadias); 2.Primary or secondary immunodeficiency disorders; 3.Severe chronic underlying diseases (e.g., malignancy, severe cardiac, hepatic, or renal dysfunction); 4.Incomplete follow-up data or inability to complete follow-up as planned; 5.Current participation in other interventional clinical trials or studies that may affect the outcomes of this study.

Design outcomes

Primary

MeasureTime frame
Vesicoureteral Reflux Grading by Voiding Cystourethrography, VCUG;

Secondary

MeasureTime frame
Urine Bacterial Culture Results;Urinary Transcriptomics;

Countries

China

Contacts

Public ContactZhao Shimeng

Hebei Children's Hospital

simonchaos@126.com+86 152 3365 6676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026